Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 2/20 | 0.37 |
| ▸ | CNR2 | P34972 | 2/20 | 0.37 |
| ▸ | TRPM8 | Q7Z2W7 | 6/20 | 0.37 |
| ▸ | NR1H2 | P55055 | 4/20 | 0.36 |
| ▸ | NR1H3 | Q13133 | 3/20 | 0.36 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | PTGES | O14684 | 1/20 | 0.33 |
| ▸ | PER2 | O15055 | 1/20 | 0.33 |
| ▸ | CRY1 | Q16526 | 1/20 | 0.33 |
| ▸ | CRY2 | Q49AN0 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4769701 | 0.92 | CNR2 (0.36) | CNR1CNR2TRPM8NR1H2NR1H3 | |
| SCHEMBL4767617 | 0.91 | TRPM8 (0.40) | TRPM8GAAKDM4EMAPT | |
| SCHEMBL4770824 | 0.90 | CNR1 (0.35) | CNR1CNR2TRPM8NR1H2NR1H3 | |
| SCHEMBL4770841 | 0.89 | CNR1 (0.37) | CNR1CNR2TRPM8NR1H2NR1H3 | |
| SCHEMBL5571164 | 0.88 | GAA (0.44) | CNR1CNR2TRPM8NR1H2NR1H3 | |
| SCHEMBL4777509 | 0.87 | CNR2 (0.37) | CNR1CNR2TRPM8NR1H2NR1H3 | |
| SCHEMBL4775014 | 0.86 | TRPM8 (0.38) | TRPM8GAAKDM4ELMNAMAPT | |
| SCHEMBL4775075 | 0.85 | CNR2 (0.37) | CNR1CNR2TRPM8NR1H2NR1H3 | |
| SCHEMBL4772347 | 0.85 | GAA (0.37) | CNR1CNR2TRPM8NR1H2NR1H3 | |
| SCHEMBL4772420 | 0.84 | GAA (0.37) | TRPM8NR1H2NR1H3GAALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070135435-A1 | Certain chemical entities, compositions, and methods | CYTOKINETICS, INCORPORATED | 2007-06-14 | — | — | US | claimed |
| US-20070135435-A1 | Certain chemical entities, compositions, and methods | CYTOKINETICS, INCORPORATED | 2007-06-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070135435-A1 | Certain chemical entities, compositions, and methods | KIF5B, KIF2C, PLK1 | CNR1 4121/4885CNR2 4377/4885TRPM8 3499/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.